MELAZTE 250 MG CAP DURA CT FR VD AMB X 5
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1029805860065 -
GGREM
506724060101004 -
Código de barras
7896676441031
O que a fonte publica
- Detentor do registro
- CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA.
- Princípios ativos
- TEMOZOLOMIDA
- Embalagem
- 250 MG CAP DURA CT FR VD AMB X 5
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- L1A - AGENTES ANTINEOPLÁSICOS ALQUILANTES
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "MELAZTE 250 MG CAP DURA CT FR VD AMB X 5",
"holder": "CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896676441031"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "506724060101004",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "44.734.671/0001-51",
"priceRegime": "Regulado",
"productName": "MELAZTE",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "250 MG CAP DURA CT FR VD AMB X 5",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "9043.67",
"icms-12": "10276.90",
"icms-17": "10895.99",
"icms-18": "11028.86",
"icms-19": "11165.03",
"icms-20": "11304.59",
"icms-21": "11447.69",
"icms-22": "11594.45",
"icms-23": "11745.02",
"icms-17.5": "10962.02",
"icms-19.5": "11234.37",
"icms-20.5": "11375.69",
"icms-22.5": "11669.26",
"icms-12-alc": "10153.57",
"icms-17-alc": "10765.23",
"icms-18-alc": "10896.52",
"icms-19-alc": "11031.04",
"icms-20-alc": "11168.92",
"icms-21-alc": "11310.31",
"icms-22-alc": "11455.31",
"icms-23-alc": "11604.08",
"withoutTaxes": "8935.15",
"icms-17.5-alc": "10830.47",
"icms-19.5-alc": "11099.56",
"icms-20.5-alc": "11239.17",
"icms-22.5-alc": "11529.22"
},
"pisCofinsList": "Positiva",
"substanceText": "TEMOZOLOMIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "12465.76",
"icms-12": "14165.64",
"icms-17": "15018.99",
"icms-18": "15202.13",
"icms-19": "15389.83",
"icms-20": "15582.20",
"icms-21": "15779.45",
"icms-22": "15981.74",
"icms-23": "16189.29",
"icms-17.5": "15110.00",
"icms-19.5": "15485.41",
"icms-20.5": "15680.20",
"icms-22.5": "16084.86",
"icms-12-alc": "14036.71",
"icms-17-alc": "14882.30",
"icms-18-alc": "15063.80",
"icms-19-alc": "15249.77",
"icms-20-alc": "15440.38",
"icms-21-alc": "15635.84",
"icms-22-alc": "15836.29",
"icms-23-alc": "16041.96",
"withoutTaxes": "12352.32",
"icms-17.5-alc": "14972.49",
"icms-19.5-alc": "15344.49",
"icms-20.5-alc": "15537.49",
"icms-22.5-alc": "15938.47"
},
"invalidBarcodes": [],
"activeSubstances": [
"TEMOZOLOMIDA"
],
"therapeuticClass": "L1A - AGENTES ANTINEOPLÁSICOS ALQUILANTES",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1029805860065",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:506724060101004"